[
    [
        {
            "time": "2018-03-01",
            "original_text": "公司获QFII连续三季度加仓，偏爱两领域，普遍越跌越买",
            "features": {
                "keywords": [
                    "QFII",
                    "加仓",
                    "越跌越买"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "公司获QFII连续三季度加仓，偏爱两领域，普遍越跌越买",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-05-15",
            "original_text": "北上资金5月“变天”：连续6日净流出，偏好低价股",
            "features": {
                "keywords": [
                    "北上资金",
                    "净流出",
                    "低价股"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北上资金5月“变天”：连续6日净流出，偏好低价股",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-04-30",
            "original_text": "医药生物行业18年报及19年一季报回顾:医药整体业绩探底,内部分化明显",
            "features": {
                "keywords": [
                    "医药生物",
                    "业绩探底",
                    "分化"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药生物行业18年报及19年一季报回顾:医药整体业绩探底,内部分化明显",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-04-10",
            "original_text": "医药生物行业2019q1业绩前瞻-2019q1医药板块整体增长稳健,个股业绩持续分化",
            "features": {
                "keywords": [
                    "医药生物",
                    "业绩增长",
                    "稳健"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业2019q1业绩前瞻-2019q1医药板块整体增长稳健,个股业绩持续分化",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-05-20",
            "original_text": "【国信医药】中国生物制药（1177.HK）：研发捷报频传，持续成长可期",
            "features": {
                "keywords": [
                    "中国生物制药",
                    "研发",
                    "成长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【国信医药】中国生物制药（1177.HK）：研发捷报频传，持续成长可期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-06-01",
            "original_text": "炸了！年销售费80亿，每天举办169场活动，这家公司还能吹多久？",
            "features": {
                "keywords": [
                    "销售费",
                    "活动",
                    "质疑"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "炸了！年销售费80亿，每天举办169场活动，这家公司还能吹多久？",
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-04-05",
            "original_text": "国金证券：从2018年上市公司年报看国内医药研发(附股)",
            "features": {
                "keywords": [
                    "医药研发",
                    "年报",
                    "国金证券"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "国金证券：从2018年上市公司年报看国内医药研发(附股)",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-05-05",
            "original_text": "【国金晨讯精选】就业压力专题研究（固收），中国医药研发专题研究",
            "features": {
                "keywords": [
                    "医药研发",
                    "专题研究",
                    "国金晨讯"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【国金晨讯精选】就业压力专题研究（固收），中国医药研发专题研究",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-05-25",
            "original_text": "5月以来两融余额下降270亿 杠杆资金逆势加仓150只潜力股",
            "features": {
                "keywords": [
                    "两融余额",
                    "杠杆资金",
                    "加仓"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "5月以来两融余额下降270亿 杠杆资金逆势加仓150只潜力股",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-03-10",
            "original_text": "中国医药行业研发专题分析报告:转型、创新、发展,中国医药研发蓬勃兴起,从2018年上市公司年报看国内医药研发",
            "features": {
                "keywords": [
                    "医药研发",
                    "转型",
                    "创新"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中国医药行业研发专题分析报告:转型、创新、发展,中国医药研发蓬勃兴起,从2018年上市公司年报看国内医药研发",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]